Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2075 USD | +0.24% | -12.11% | -86.07% |
Apr. 16 | Barnes & Noble Education to Receive $95 Million Investment, Adopts Short-Term Poison Pill; Shares Plunge | MT |
Apr. 16 | Barnes & Noble Education Adopts Short-Term Poison Pill | MT |
Financials (USD)
Sales 2024 * | 1.58B | Sales 2025 * | 1.62B | Capitalization | 11.03M |
---|---|---|---|---|---|
Net income 2024 * | -56M | Net income 2025 * | -19M | EV / Sales 2024 * | 0.01 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.01 x |
P/E ratio 2024 * |
-0.2
x | P/E ratio 2025 * |
-0.56
x | Employees | 3,450 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.73% |
Latest transcript on Barnes & Noble Education, Inc.
1 day | +0.24% | ||
1 week | -12.11% | ||
Current month | -71.35% | ||
1 month | -67.98% | ||
3 months | -78.03% | ||
6 months | -79.85% | ||
Current year | -86.07% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Huseby
CEO | Chief Executive Officer | 69 | 13-12-31 |
Kevin Watson
DFI | Director of Finance/CFO | 57 | 23-09-06 |
Stephen Culver
CTO | Chief Tech/Sci/R&D Officer | 59 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Huseby
CEO | Chief Executive Officer | 69 | 13-12-31 |
David Golden
BRD | Director/Board Member | 66 | 15-08-01 |
John Ryan
CHM | Chairman | 79 | 15-07-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.2075 | +0.24% | 1,854,722 |
24-04-24 | 0.207 | +0.29% | 1,045,448 |
24-04-23 | 0.2064 | +2.64% | 1,460,859 |
24-04-22 | 0.2011 | -13.62% | 2,514,861 |
24-04-19 | 0.2328 | -1.40% | 1,406,587 |
Delayed Quote Nyse, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.07% | 11M | |
+45.53% | 220M | |
+50.99% | 67.04M |
- Stock Market
- Equities
- BNED Stock